By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Symphogen A/S 

Elektrovej
Building 37
Lyngby    DK-2800  Denmark
Phone: 45-45-26-50-50 Fax: 45-45-26-50-60


SEARCH JOBS


Industry
Biotechnology






Company News
Symphogen A/S To Report Preliminary Safety And Exploratory Efficacy Data From A Phase 1 Study Of Sym004, Anti-EGFR Monoclonal Antibody Mixture At American Society of Clinical Oncology 5/29/2014 7:27:03 AM
Symphogen A/S Finds A New Home, Appoints Chief Manufacturing Officer 5/19/2014 6:46:30 AM
Symphogen A/S Presents Corporate Progress And Outlook at JP Morgan's 32nd Annual Healthcare Conference In San Francisco, CA 1/15/2014 6:30:33 AM
Symphogen A/S Presents Corporate Progress And Outlook At JP Morgan's 32nd Annual Healthcare Conference In San Francisco, CA 1/14/2014 12:10:10 PM
Symphogen A/S Presents Corporate Progress And Outlook At JP Morgan's 32nd Annual Healthcare Conference In San Francisco, CA 1/14/2014 11:50:53 AM
Symphogen A/S Announces The Appointment Of Annika Espander Jansson As Non-Executive Director 12/20/2013 6:37:27 AM
Symphogen A/S and Open Monoclonal Technology, Inc. Announce Collaboration 10/15/2013 10:43:56 AM
Symphogen A/S Receives Milestone Payment in Merck KGaA (MKGAF.PK) Sym004 Collaboration 6/26/2013 11:11:04 AM
Symphogen A/S to Report New Data on Anti-EGFR Monoclonal Antibody Mixture at American Society of Clinical Oncology 5/30/2013 7:03:18 AM
Symphogen A/S Raises $186 Million to Advance Cancer-Drug Pipeline 5/2/2013 7:42:42 AM
123456
//-->